Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)

Published
  • On an Intent-to-Treat Analysis, Co-Primary Symptom Endpoint Met, Statistical Significance (P

In This Story

PTN